BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2024 8:01:41 AM | Browse: 331 | Download: 1106
Publication Name World Journal of Transplantation
Manuscript ID 90554
Country Bulgaria
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Minireviews
Article Title Controversies regarding transplantation of mesenchymal stem cells
Manuscript Source Invited Manuscript
All Author List Tsvetelina Velikova, Tereza Dekova and Dimitrina Georgieva Miteva
ORCID
Author(s) ORCID Number
Tereza Dekova http://orcid.org/0000-0002-4376-2780
Funding Agency and Grant Number
Funding Agency Grant Number
The National Recovery and Resilience Plan of the Republic of Bulgaria No. BG-RRP-2.004-0008-C01
Corresponding Author Tereza Dekova, PhD, Assistant Professor, Department of Genetics, Faculty of Biology, Sofia University St. Kliment Ohridski, 8 Dragan Tzankov Str , Sofia 1164, Bulgaria. dekova@biofac.uni-sofia.bg
Key Words Mesenchymal stem cells; Transplantation controversies; Regenerative medicine; Autoimmune diseases; Chronic inflammatory illnesses; Tumor growth; Metastasis; Therapeutic potential; Clinical use of mesenchymal stem cell
Core Tip Controversies surrounding mesenchymal stem cell (MSC) transplantation demand nuanced evaluation. Autologous vs allogeneic choices, long-term efficacy, and safety remain hot topics. Understanding the mechanisms of homing, integration, and paracrine signaling is vital for predictable outcomes. Standardization, regulatory clarity, and cost considerations require urgent attention. Combining MSCs with other therapies offers a promising horizon. Ethical, legal, and publication quality concerns persist. Rigorous research, informed patient selection and personalized strategies are paramount. In this dynamic field, our review underscores the need for clarity, transparency, and evidence-based practice to harness the transformative potential of MSCs effectively
Publish Date 2024-06-14 08:01
Citation

Velikova T, Dekova T, Miteva DG. Controversies regarding transplantation of mesenchymal stem cells. World J Transplant 2024; 14(2): 90554

URL https://www.wjgnet.com/2220-3230/full/v14/i2/90554.htm
DOI https://dx.doi.org/10.5500/wjt.v14.i2.90554
Full Article (PDF) WJT-14-90554-with-cover.pdf